Results 121 to 130 of about 63,594 (281)
Answering Unanswerable Questions in the Clinical Laboratory with Data Warehouses [PDF]
Clinical Chemistry, 2019 Laboratorians face many “unanswerable” questions in their daily work. What caused a false-positive test in this patient, when all the known interferences have been ruled out? How can I identify mislabeled specimens in the laboratory, when all I have are the specimens themselves? Does this patient really need that test? None of these questions is truly
openaire +2 more sources
AI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective
Advanced Intelligent Discovery, EarlyView.The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.
Shilong Liu, Shunxiang Li, Kun Qian
wiley +1 more source
Barriers to the adoption of health information technology [PDF]
, 2011 Information Technology (IT) is successfully applied in a diverse range of fields. Though, the field of Medical Informatics is more than three decades old, it shows a very slow progress compared to many other fields in which the application of IT is ...
Nugawela, Saliya, Sahama, Tony
core +1 more source
Large‐Scale Machine Learning to Screen for Small‐Molecule Senolytics
Advanced Intelligent Discovery, EarlyView.A consistent workflow underpins all experiments in this study. A dedicated model‐selection dataset first identifies optimal hyperparameters for each algorithm. Models are then trained and rigorously evaluated on independent sets of molecules using the senolytic ratio SR. Comprehensive hyperparameter exploration across SMILES representations, task types,
Alexis Dougha +2 more
wiley +1 more source
HealthCare Partners: Building on a Foundation of Global Risk Management to Achieve Accountable Care [PDF]
, 2012 Describes the progress of a medical group and independent practice association in forming an accountable care organization by working with insurers as part of the Brookings-Dartmouth ACO Pilot Program.
Aricca D. Van Citters +7 more
core
Measurement of Cumulative Drug Exposure from Clinical Data Warehouse
Polypharmacy (PP) and hyperpolypharmacy (HPP), are prevalent among cancer patients and are associated with an increased risk of drug-drug interactions (DDI) and potentially inappropriate medications (PIM). This study aimed to characterize PP, HPP, DDI, and PIM in patients with hematological malignancies hospitalized for hematopoietic stem cell ...
Bories, Mathilde +4 more
openaire +2 more sources
Arthroscopy, EarlyView.Purpose To compare the anterior–posterior distance ratio of the lateral‐to‐medial tibial plateau (LTP/MTP) among 3 patient groups: those with intact anterior cruciate ligaments (ACLi), primary ACL tears (ACLp), and failed ACL reconstructions (ACLf).
Hansel E. Ihn +6 more
wiley +1 more source
Late‐Onset Rheumatoid Arthritis and Air Pollution in the Multiethnic Cohort
Arthritis &Rheumatology, EarlyView.Objective To evaluate the effects of ambient air pollution on rheumatoid arthritis (RA) incidence in a racially and ethnically diverse population. Methods This analysis included 42,152 California Multiethnic Cohort participants, aged ≥65 years (>70% African American and Latino adults) who were enrolled in the Fee For Service component of Medicare (2001–
Anna H. Wu +14 more
wiley +1 more source
Arthritis &Rheumatology, EarlyView.Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using National Veterans Health Administration, Medicare, and National Death Index data (2006–2020).
Tate M. Johnson +13 more
wiley +1 more source